window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : September 9, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Pharmaceuticals and therapeutics

  • Clinical & Regulatory,Drug Delivery & Formulation,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics

    Dunbar Pharma brings plant-derived dronabinol API to UK through IPS Pharma

    Dunbar Pharma has made its plant-derived dronabinol active pharmaceutical ingredient [...]

    August 20, 2026
  • Central Nervous System,Clinical & Regulatory,Digital & Data,Pharmaceuticals and therapeutics,Therapeutic Areas

    Limbic selected for FDA pilot to test AI-led mental healthcare

    Limbic has been selected for the US Food and Drug [...]

    August 19, 2026
  • Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    Pusan National University study links stress signalling to immune escape in cold tumours

    A Pusan National University study has identified a signalling pathway [...]

    August 19, 2026
  • Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas

    Hansa Biopharma treats first commercial kidney transplant patient with Idefirix in Australia

    Hansa Biopharma has treated the first commercial Australian living donor [...]

    August 19, 2026
  • Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas

    NICE recommends glycopyrronium cream for severe underarm sweating

    NICE has recommended glycopyrronium bromide cream as an option for [...]

    August 17, 2026
  • Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas

    NICE recommends allergy immunotherapy tablets for children with hay fever and house dust mite allergy

    NICE has recommended sublingual immunotherapy tablets for children with moderate [...]

    August 17, 2026
  • Digital & Data,Pharmaceuticals and therapeutics,Therapeutic Areas

    Tris Pharma partners with Calm Health and ADHD Central to support patients

    Tris Pharma has announced partnerships with Calm Health and ADHD [...]

    August 14, 2026
  • Drug Discovery & Development,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics,Research & Development

    US FDA inspects Aurisco site for generic oligonucleotide manufacturing

    The US FDA has completed a pre-approval inspection of Aurisco [...]

    August 14, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development

    Remepy raises $36M to advance Parkinson’s drug into Phase 3

    Remepy has raised $36M in a Series A financing round [...]

    August 14, 2026
  • Clinical & Regulatory,Drug Delivery & Formulation,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    FDA grants Priority Review to Belite Bio’s tinlarebant for Stargardt disease

    The FDA has accepted Belite Bio’s application for tinlarebant and [...]

    August 13, 2026
Previous234Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Polaryx advances Phase 2 trial of PLX-200 in four rare diseases
    Categories: Clinical & Regulatory, Drug Discovery & Development, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • Lumen Bioscience gets up to $7M to advance LMN-1001 into Phase 1
    Categories: Advanced Therapies, Clinical & Regulatory, Drug Discovery & Development, Pharmaceuticals and therapeutics, Research & Development
  • Brainomix to present five ILD studies on quantitative CT at ERS Congress
    Categories: Advanced Therapies, Clinical & Regulatory, Digital & Data, Research & Development, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top